AARD News

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Class Action Litigation Now Underway by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD

AARD DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

Class Action Filing Pursued by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD

Class Action Litigation Filed by Pomerantz LLP for Investors of Aardvark Therapeutics, Inc. – AARD

AARD FINAL DEADLINE: ROSEN, A TRUSTED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

Class Action Filing Initiated by Pomerantz LLP Concerning Aardvark Therapeutics, Inc. – AARD

Class Action Litigation Filed by Pomerantz LLP Concerning Aardvark Therapeutics, Inc. – AARD

AARD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 Ready to Announce with Confidence?